CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Oxford BioMedica plc Company Snapshot
Oxford BioMedica plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oxford BioMedica plc with three other companies in this sector in UNITED KINGDOM : Tissue Regenix Group PLC (2019 sales of £13.03 million [US$17.35 million] of which 52% was Orthopaedics), Ergomed PLC (£68.26 million [US$90.89 million] of which 52% was Pharmacovigilance), and MaxCyte Inc (£16.90 million [US$22.51 million] of which 100% was Medical Service).

Sales Analysis. During the year ended December of 2019, sales at Oxford BioMedica plc were £64.06 million (US$85.30 million). This is a decrease of 4.1% versus 2018, when the company's sales were £66.78 million. Contributing to the drop in overall sales was the 7.3% decline in Platform, from £55.00 million to £51.00 million. . However, these declines were partially offset by the increase in sales of Products (up 10.9% to £13.06 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Oxford BioMedica plc
  Stock Performance Chart for Oxford BioMedica plc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2020): 865.00p
(Figures in Pounds Sterling)
1 Week -0.3%   13 Weeks 7.6%  
4 Weeks 2.5%   52 Weeks 38.8%  
 
Oxford BioMedica plc Key Data:
  Ticker: OXB Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 64,060,000
(Year Ending Jan 2020).
Employees: 500
  Currency: Pounds Sterling Market Cap: 709,706,515
  Fiscal Yr Ends: December Shares Outstanding: 82,046,996
  Share Type: Ordinary Closely Held Shares: 13,444,364
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.